These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 33929613)
21. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells. Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166 [TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis. Morales-Sanchez A; Fuentes-Panana EM Curr Cancer Drug Targets; 2017; 17(6):534-554. PubMed ID: 27677953 [TBL] [Abstract][Full Text] [Related]
23. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844 [TBL] [Abstract][Full Text] [Related]
24. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528 [TBL] [Abstract][Full Text] [Related]
25. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425 [TBL] [Abstract][Full Text] [Related]
26. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China. Sun L; Zhao Z; Liu S; Liu X; Sun Z; Luo B PLoS One; 2015; 10(10):e0140529. PubMed ID: 26460969 [TBL] [Abstract][Full Text] [Related]
27. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription. Liu CD; Lee HL; Peng CW J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781 [TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC). Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899 [TBL] [Abstract][Full Text] [Related]
29. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Wang Y; Liu X; Xing X; Cui Y; Zhao C; Luo B Virus Res; 2010 Feb; 147(2):258-64. PubMed ID: 19941915 [TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers. Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; FĂ„hraeus R J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded miR-BART11-3p modulates the DUSP6-MAPK axis to promote gastric cancer cell proliferation and metastasis. Xu M; Lin J; Yang S; Yao J; Chen M; Feng J; Zhang L; Zhou L; Zhang J; Qin Q J Virol; 2023 Sep; 97(9):e0088123. PubMed ID: 37681959 [TBL] [Abstract][Full Text] [Related]
32. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023 [TBL] [Abstract][Full Text] [Related]
33. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Westhoff Smith D; Sugden B Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328 [TBL] [Abstract][Full Text] [Related]
34. Cancer stem cells in Epstein-Barr virus-associated gastric carcinoma. Yasui M; Kunita A; Numakura S; Uozaki H; Ushiku T; Fukayama M Cancer Sci; 2020 Jul; 111(7):2598-2607. PubMed ID: 32338409 [TBL] [Abstract][Full Text] [Related]
35. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome. Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954 [TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy. Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567 [TBL] [Abstract][Full Text] [Related]
37. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma. Borozan I; Zapatka M; Frappier L; Ferretti V J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus Regulates Endothelin-1 Expression through the ERK/FOXO1 Pathway in EBV-Associated Gastric Cancer. Liu W; Zhang Q; Zhang Y; Sun L; Xiao H; Luo B Microbiol Spectr; 2023 Feb; 11(1):e0089822. PubMed ID: 36475746 [TBL] [Abstract][Full Text] [Related]
40. Is gastric lymphoepithelioma-like carcinoma a special subtype of EBV-associated gastric carcinoma? New insight based on clinicopathological features and EBV genome polymorphisms. Cheng N; Hui DY; Liu Y; Zhang NN; Jiang Y; Han J; Li HG; Ding YG; Du H; Chen JN; Shao CK Gastric Cancer; 2015 Apr; 18(2):246-55. PubMed ID: 24771002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]